Cochrane Abstracts
Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Janus Kinase‐1 and Janus Kinase‐2 Inhibitors for Treating Myelofibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis.
Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis. Accessed December 2, 2024.
Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis
Janus Kinase‐1 and Janus Kinase‐2 Inhibitors for Treating Myelofibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis
ID - 437055
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437055/all/Janus_kinase‐1_and_Janus_kinase‐2_inhibitors_for_treating_myelofibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
